FI106214B - NANBV-diagnostik: Polynukleotider användbara vid screening av hepatit-C-virus - Google Patents

NANBV-diagnostik: Polynukleotider användbara vid screening av hepatit-C-virus Download PDF

Info

Publication number
FI106214B
FI106214B FI930582A FI930582A FI106214B FI 106214 B FI106214 B FI 106214B FI 930582 A FI930582 A FI 930582A FI 930582 A FI930582 A FI 930582A FI 106214 B FI106214 B FI 106214B
Authority
FI
Finland
Prior art keywords
sequence
hcv
polynucleotide
oligonucleotide
sequences
Prior art date
Application number
FI930582A
Other languages
English (en)
Finnish (fi)
Other versions
FI930582A0 (fi
FI930582A (fi
Inventor
Michael Houghton
Qui-Lim Choo
George Kuo
Amy J Weiner
Janice A Kolberg
Michael Steven Urdea
Jang Han
Bruce Duncan Irvine
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of FI930582A0 publication Critical patent/FI930582A0/fi
Publication of FI930582A publication Critical patent/FI930582A/fi
Application granted granted Critical
Publication of FI106214B publication Critical patent/FI106214B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI930582A 1990-08-10 1993-02-10 NANBV-diagnostik: Polynukleotider användbara vid screening av hepatit-C-virus FI106214B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US56620990A 1990-08-10 1990-08-10
US56620990 1990-08-10
US9105728 1991-08-12
PCT/US1991/005728 WO1992002642A1 (en) 1990-08-10 1991-08-12 Nanbv diagnostics: polynucleotides useful for screening for hepatitis c virus

Publications (3)

Publication Number Publication Date
FI930582A0 FI930582A0 (fi) 1993-02-10
FI930582A FI930582A (fi) 1993-04-07
FI106214B true FI106214B (sv) 2000-12-15

Family

ID=24261960

Family Applications (1)

Application Number Title Priority Date Filing Date
FI930582A FI106214B (sv) 1990-08-10 1993-02-10 NANBV-diagnostik: Polynukleotider användbara vid screening av hepatit-C-virus

Country Status (19)

Country Link
EP (1) EP0543924B1 (sv)
JP (1) JP2714255B2 (sv)
KR (1) KR0163964B1 (sv)
AT (1) ATE154646T1 (sv)
AU (1) AU660940B2 (sv)
BG (1) BG61615B1 (sv)
CA (1) CA2089080C (sv)
CZ (1) CZ282573B6 (sv)
DE (1) DE69126617T2 (sv)
DK (1) DK0543924T3 (sv)
ES (1) ES2104720T4 (sv)
FI (1) FI106214B (sv)
GR (1) GR3024480T3 (sv)
HU (2) HUT69140A (sv)
NO (1) NO308621B1 (sv)
PL (1) PL169035B1 (sv)
RO (1) RO109952B1 (sv)
RU (1) RU2180354C2 (sv)
WO (1) WO1992002642A1 (sv)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0571554A1 (en) * 1991-01-14 1993-12-01 James N. Gamble Institute Of Medical Research Basic structural immunogenic polypeptides having epitopes for hcv, antibodies, polynucleotide sequences, vaccines and methods
DE69232871T2 (de) * 1991-06-24 2003-05-08 Chiron Corp Polypeptide des hepatitis c-virus (hiv)
EP0787807B1 (en) * 1991-08-27 2003-05-28 F. Hoffmann-La Roche Ag Primers and probes for hepatitis C detection
US5427909A (en) * 1991-09-09 1995-06-27 Immuno Japan Inc. Oligonucleotides and determination system of HCV genotypes
CA2123875C (en) 1991-11-21 2005-05-24 Peter Simmons Hepatitis-c virus testing
EP1262560A2 (en) * 1992-05-29 2002-12-04 Abbott Laboratories Method of forming cDNA from an RNA target sequence present in a sample
JPH0670800A (ja) * 1992-08-26 1994-03-15 Imuno Japan:Kk Ｈｃｖゲノムの多様性検出方法、プライマー
DE69330372T2 (de) * 1992-09-10 2002-03-14 Isis Pharmaceuticals Inc ZUSAMMENSETZUNGEN UND VERFAHREN FüR DIE BEHANDLUNG VON MIT HEPATITIS C VIREN ASSOZIIERTEN KRANKHEITEN
US7258977B1 (en) 1992-11-27 2007-08-21 Innogenetics N.V. Process for typing of HCV isolates
DK0637342T3 (da) * 1992-11-27 1999-11-01 Innogenetics Nv Fremgangsmåde til typebestemmelse af HCV-isolater
JPH0775585A (ja) * 1993-06-14 1995-03-20 Immuno Japan:Kk Ｃ型肝炎ウイルス関連オリゴヌクレオチドならびにｃ型肝炎 ウイルス遺伝子型判定方法
US7022830B2 (en) 2000-08-17 2006-04-04 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
RU2286172C2 (ru) 2000-08-17 2006-10-27 Трипеп Аб Вакцины, содержащие рибавирин, и способы их использования
US6680059B2 (en) 2000-08-29 2004-01-20 Tripep Ab Vaccines containing ribavirin and methods of use thereof
WO2002014362A2 (en) 2000-08-17 2002-02-21 Tripep Ab A hepatitis c virus non-structural ns3/4a fusion gene
US6586584B2 (en) 2001-01-29 2003-07-01 Becton, Dickinson And Company Sequences and methods for detection of Hepatitis C virus
US7196183B2 (en) 2001-08-31 2007-03-27 Innogenetics N.V. Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
EP1540011B1 (en) * 2002-07-26 2010-01-06 Abbott Laboratories Method of detecting and quantifying hepatitis c virus
US8124747B2 (en) 2003-08-29 2012-02-28 Innogenetics HCV clade and prototype sequences thereof
WO2007031867A2 (en) 2005-05-25 2007-03-22 Tripep Ab A hepatitis c virus non-stru tural ns3/4a fusion gene
US8071561B2 (en) 2007-08-16 2011-12-06 Chrontech Pharma Ab Immunogen platform
US20090214593A1 (en) 2007-08-16 2009-08-27 Tripep Ab Immunogen platform

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
EP0458909A1 (en) * 1989-02-14 1991-12-04 Biogen, Inc. Oligonucleotide primer pairs for sequence independent gene amplification and methods which employ them
HUT54896A (en) * 1989-03-17 1991-04-29 Chiron Corp Process for producing aquous diagnosticum and vaccine of nanbv
GEP20002164B (en) * 1989-05-18 2000-07-10 Novartis Vaccines & Diagnostic Oligomers, method for detecting of hcv sequence, kit for its detecting, method for production of the blood free from hcv
CA2044296A1 (en) * 1990-06-12 1991-12-13 Hiroaki Okamoto Oligonucleotide primers, and their application for high-fidelity detection of non-a, non-b hepatitis virus
EP0464287A1 (en) * 1990-06-25 1992-01-08 The Research Foundation for Microbial Diseases of Osaka University Non-A, non-B hepatitis virus genomic cDNA and antigen polypeptide
ES2100185T3 (es) * 1990-07-11 1997-06-16 Shionogi & Co Secuencia de adnc y deteccion del virus de la hepatitis c.

Also Published As

Publication number Publication date
AU8509991A (en) 1992-03-02
GR3024480T3 (en) 1997-11-28
KR0163964B1 (ko) 1998-11-16
FI930582A0 (fi) 1993-02-10
BG97435A (bg) 1994-03-24
CA2089080A1 (en) 1992-02-11
ES2104720T4 (es) 1997-12-16
CZ16793A3 (en) 1993-05-12
DK0543924T3 (da) 1997-09-08
DE69126617T2 (de) 1997-10-02
NO930429L (no) 1993-04-05
RO109952B1 (ro) 1995-07-28
HU227499B1 (en) 2011-07-28
PL169035B1 (pl) 1996-05-31
BG61615B1 (bg) 1998-01-30
HU9300323D0 (en) 1993-05-28
JP2714255B2 (ja) 1998-02-16
ATE154646T1 (de) 1997-07-15
EP0543924A1 (en) 1993-06-02
ES2104720T3 (es) 1997-10-16
WO1992002642A1 (en) 1992-02-20
NO308621B1 (no) 2000-10-02
RU2180354C2 (ru) 2002-03-10
EP0543924A4 (en) 1993-07-21
CA2089080C (en) 2007-04-03
HUT69140A (en) 1995-08-28
FI930582A (fi) 1993-04-07
CZ282573B6 (cs) 1997-08-13
EP0543924B1 (en) 1997-06-18
NO930429D0 (no) 1993-02-08
AU660940B2 (en) 1995-07-13
JPH06503707A (ja) 1994-04-28
DE69126617D1 (de) 1997-07-24

Similar Documents

Publication Publication Date Title
JP3698520B2 (ja) Ｎａｎｂｖの診断法：ｃ型肝炎ウイルスのスクリーニングに有用なポリヌクレオチド
FI106214B (sv) NANBV-diagnostik: Polynukleotider användbara vid screening av hepatit-C-virus
US5863719A (en) Methods for detecting hepatitis C virus using polynucleotides specific for same
US5714596A (en) NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus
Holland et al. Genotyping hepatitis C virus isolates from Spain, Brazil, China, and Macau by a simplified PCR method
JP2007068542A (ja) Ｈｃｖを遺伝子型分類するためのヘテロ二本鎖トラッキングアッセイ（ｈｔａ）
Adams et al. Complete coding sequence of hepatitis C virus genotype 6a
RU2145635C1 (ru) Олигомер (варианты), способ обнаружения последовательности hcv (варианты), набор для обнаружения, способ получения крови
PT94081B (pt) Diagnosticos para o nambv: polinucleotidos uteis na deteccao do virus da hepatite c
KR20070037228A (ko) Ｈｃｖ 특이 유전자 검출키트

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: NOVARTIS VACCINES AND DIAGNOSTICS, INC.

Free format text: NOVARTIS VACCINES AND DIAGNOSTICS, INC.

MA Patent expired